Detailed TOC of Global Parkinson's Disease Therapeutics Report, Competitive Landscape, Market Size, Regional Status and Prospect
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Market by Application
1.3.1 Global Parkinson's Disease Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease Therapeutics Market Perspective (2018-2029)
2.2 Parkinson's Disease Therapeutics Growth Trends by Region
2.2.1 Global Parkinson's Disease Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Parkinson's Disease Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Parkinson's Disease Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Parkinson's Disease Therapeutics Market Dynamics
2.3.1 Parkinson's Disease Therapeutics Industry Trends
2.3.2 Parkinson's Disease Therapeutics Market Drivers
2.3.3 Parkinson's Disease Therapeutics Market Challenges
2.3.4 Parkinson's Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson's Disease Therapeutics Players by Revenue
3.1.1 Global Top Parkinson's Disease Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Parkinson's Disease Therapeutics Revenue
3.4 Global Parkinson's Disease Therapeutics Market Concentration Ratio
3.4.1 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Therapeutics Revenue in 2022
3.5 Parkinson's Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Parkinson's Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Parkinson's Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Therapeutics Breakdown Data by Type
4.1 Global Parkinson's Disease Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2024-2029)
5 Parkinson's Disease Therapeutics Breakdown Data by Application
5.1 Global Parkinson's Disease Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Parkinson's Disease Therapeutics Market Size (2018-2029)
6.2 North America Parkinson's Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Parkinson's Disease Therapeutics Market Size by Country (2018-2023)
6.4 North America Parkinson's Disease Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Parkinson's Disease Therapeutics Market Size (2018-2029)
7.2 Europe Parkinson's Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Parkinson's Disease Therapeutics Market Size by Country (2018-2023)
7.4 Europe Parkinson's Disease Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Parkinson's Disease Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific Parkinson's Disease Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Parkinson's Disease Therapeutics Market Size (2018-2029)
9.2 Latin America Parkinson's Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Parkinson's Disease Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Parkinson's Disease Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa Parkinson's Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Parkinson's Disease Therapeutics Introduction
11.1.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.1.5 Merck Recent Development
11.2 Akorn
11.2.1 Akorn Company Detail
11.2.2 Akorn Business Overview
11.2.3 Akorn Parkinson's Disease Therapeutics Introduction
11.2.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.2.5 Akorn Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson's Disease Therapeutics Introduction
11.3.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Parkinson's Disease Therapeutics Introduction
11.4.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Detail
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Introduction
11.6.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.6.5 Teva Pharmaceutical Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Detail
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson's Disease Therapeutics Introduction
11.7.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.7.5 Abbvie Recent Development
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Detail
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.8.5 Kyowa Hakko Kirin Pharma Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Detail
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson's Disease Therapeutics Introduction
11.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.9.5 Astellas Pharma Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche Parkinson's Disease Therapeutics Introduction
11.10.4 Roche Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.10.5 Roche Recent Development
11.11 H.Lundbeck
11.11.1 H.Lundbeck Company Detail
11.11.2 H.Lundbeck Business Overview
11.11.3 H.Lundbeck Parkinson's Disease Therapeutics Introduction
11.11.4 H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.11.5 H.Lundbeck Recent Development
11.12 Bausch Health
11.12.1 Bausch Health Company Detail
11.12.2 Bausch Health Business Overview
11.12.3 Bausch Health Parkinson's Disease Therapeutics Introduction
11.12.4 Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.12.5 Bausch Health Recent Development
11.13 Apokyn
11.13.1 Apokyn Company Detail
11.13.2 Apokyn Business Overview
11.13.3 Apokyn Parkinson's Disease Therapeutics Introduction
11.13.4 Apokyn Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.13.5 Apokyn Recent Development
11.14 Orion
11.14.1 Orion Company Detail
11.14.2 Orion Business Overview
11.14.3 Orion Parkinson's Disease Therapeutics Introduction
11.14.4 Orion Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.14.5 Orion Recent Development
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Detail
11.15.2 Stada Arzneimittel Business Overview
11.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Introduction
11.15.4 Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.15.5 Stada Arzneimittel Recent Development
11.16 US WorldMeds
11.16.1 US WorldMeds Company Detail
11.16.2 US WorldMeds Business Overview
11.16.3 US WorldMeds Parkinson's Disease Therapeutics Introduction
11.16.4 US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.16.5 US WorldMeds Recent Development
11.17 Desitin Arzneimittel
11.17.1 Desitin Arzneimittel Company Detail
11.17.2 Desitin Arzneimittel Business Overview
11.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Introduction
11.17.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.17.5 Desitin Arzneimittel Recent Development
11.18 Endo Pharmaceuticals
11.18.1 Endo Pharmaceuticals Company Detail
11.18.2 Endo Pharmaceuticals Business Overview
11.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Introduction
11.18.4 Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.18.5 Endo Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Download FREE Sample Report
